National Institute of Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
Location status: Recruiting
NCT Number: NCT01324206
Background:
- Magnetic resonance imaging (MRI) studies provide important information on the structure and function of various body systems, including the brain, muscles, joints, heart, and blood vessels. Scientific applications of MRI scans often use techniques that need to be modified or refined before they are used in clinical studies. To develop and modify these techniques for the new Philips 3T Achieva whole-body MRI scanner, researchers are interested in conducting trial MRI scans on healthy individuals and individuals with conditions that require imaging studies.
Objectives:
- To conduct preliminary trials of the 3T MRI facility to develop and refine MRI scanning procedures.
Eligibility:
- Individuals at least 18 years of age who are able to have magnetic resonance imaging.
Design:
* Participants will be screened with a full medical history and physical examination, as well as blood and urine tests. * Participants will have an MRI scan using the 3T scanner. Some scans may require the use of a contrast agent or radiotracer, which is a small amount of radioactive substance that will be injected before the start of the scan. Some participants may be asked to perform tasks of thinking and movement while in the scanner, in order to test the procedures required for a functional MRI scan. * No treatment will be provided as part of this protocol.
Interested in participating?
Request Info18 year–99 year
All sexes
Observational
Baltimore, Maryland, 21224, United States
Location status: Recruiting
Study Description:
The purpose of this protocol is to permit use of the magnetic resonance imaging (MRI) facility for the development and refinement of MRI and spectroscopy (MRIS) scanning procedures. The information obtained through these methodological assessments will be essential future clinical research investigations conducted through the NIA under specific protocols. Additionally, this data can be utilized in already approved NIA studies for comparison purposes.
Objectives:
Primary Objective: To develop and refine specific MR imaging and spectroscopy methods.
Secondary Objectives: To allow pilot tests of procedures for development and refinement of motor or cognitive activation paradigms.
Endpoints:
Development of noninvasive MR biomarkers to assess longevity, healthy longevity, physical disability, cognitive impairment, and frailty.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
To be eligible to participate in this study, an individual must meet all the following criteria:
Exclusion criteria
An individual who meets any of the following criteria will be excluded from participation in this study:
Time frame: 2 months
To develop and refine specific imaging and spectroscopic methods.
Contact information is provided by the study sponsor or research team.
Mustapha Bouhrara, Ph.D.
CONTACT
Seung-Ho Park, R.N.
CONTACT
National Institute on Aging (NIA)
Nih
Development of Magnetic Resonance Imaging and Spectroscopy Research Methods for NIA Studies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00109174
Normal Physiology
Bethesda, Maryland, United States
View Trial DetailsNCT06561828
Normal Physiology
Baltimore, Maryland, United States
View Trial DetailsNCT02446262
Healthy Volunteers, Neurologic Manifestations
Bethesda, Maryland, United States
View Trial DetailsNCT02583646
Body Weight, Normal Physiology
Research Triangle Park, North Carolina, United States
View Trial Details